Vivek Subbiah/X
Jun 3, 2025, 10:33
Vivek Subbiah: Waiting for ASCO 2025 Hematology Discussions with Naveen Pemmaraju
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on X:
“Love ASCO because I can just crash into meetings. Popcorn secured – now waiting for Naveen Pemmaraju to serve up the hematology drama, plot twists, and award-winning stories. Someone cue the theme music!”
Read OncoDaily’s Special Articles about American Society of Clinical Oncology 2025 Annual Meeting:
Highlights from American Society of Clinical Oncology 2025 Annual Meeting: Day 1
Highlights from American Society of Clinical Oncology 2025 Annual Meeting: Day 2
Highlights from American Society of Clinical Oncology 2025 Annual Meeting: Day 3
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 14, 2025, 15:19
Aug 14, 2025, 15:07
Aug 14, 2025, 14:53
Aug 14, 2025, 14:46
Aug 14, 2025, 14:32
Aug 14, 2025, 13:57
Aug 14, 2025, 13:22
Aug 14, 2025, 12:56
Aug 14, 2025, 12:48
Aug 14, 2025, 12:44
Aug 14, 2025, 12:33